JCNF Applauds Trump for Calling Out Regulation that Harms Innovation, Restricts Patient Choice

Washington, D.C. (April 16, 2025)—This week, the Trump administration issued an executive order calling on HHS Secretary RFK Jr. to work with Congress on addressing government manipulation within the prescription drug market. More specifically, the White House highlighted a particularly problematic regulation called the “pill penalty,” which distorts investment in new small molecule drugs—typically taken in pill form—versus biologic products administered in a clinical setting.

Legislation nicknamed the EPIC Act has already been proposed in Congress to address the problem. In the wake of President Trump’s directive, lawmakers should push the bill forward.

Elaine Parker, President of the Job Creators Network Foundation, released the following statement:

“The federal government has no place picking winners and losers in the free market. In the case of healthcare, too much government red tape harms innovation and restricts patient choice. I applaud President Trump’s actions to level the playing field and urge Congress to follow his lead to cement the executive directive into law. Healthcare reform should be rooted in competition, choice, and transparency, not bureaucratic manipulation.”

Read Elaine Parker’s latest op-ed on the topic in RealClear Health.